ORBIA:BMVOrbia Advance Corp. SAB de CV Analysis

Orbia posted Q1 2026 revenue of $1.96 B, up 8% YoY, and EBITDA of $259 M, up 31% YoY, indicating strong earnings momentum. The stock trades at MXN 21.94, near its 20‑day SMA of 22.32 and above the 20.29 support, while the 200‑day SMA sits at 18.00, confirming a bullish medium‑term trend. Technicals show RSI 48.7 (neutral) and a bearish MACD histogram, suggesting short‑term caution but not a sell signal. The dividend yield stands at an eye‑catching 9.79% with a reported payout ratio of 0, raising questions about sustainability. Valuation models give a DCF‑derived fair value implying roughly 26% upside, and the stock trades well below the industry PE average of 29.7, supporting an undervalued view.
However, profitability remains a concern: trailing profit margin is –5.7% and ROE is –12%, while debt‑to‑equity is a high 213, indicating leverage risk. Beta of 0.47 and 30‑day volatility of 26% point to modest market sensitivity but notable price swings. Geographic exposure across North America, Europe, Latin America and emerging markets adds medium‑high geographic risk, and the chemical segment faces moderate regulatory scrutiny. Given the strong earnings momentum, attractive dividend and valuation upside, the stock appears positioned for upside, but investors should monitor debt levels and dividend sustainability. Overall, a cautious but optimistic stance is warranted.